Correction: Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population
Open Access
- 6 April 2026
- journal article
- correction
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 75 (5) , 138